JOURNEY MED CORP DERM
COM · Common Stock · CUSIP 48115J109
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersScottsdale, AZ
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $3.74.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2021 | 15 |
| Q1 2022 | 15 |
| Q2 2022 | 14 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2022 | 7 | 10 |
| Q2 2022 | 7 | 9 |
Biggest buyers
| Opaleye Management Inc. | Added | +178.7k |
| PERKINS CAPITAL MANAGEMENT INC | Added | +28.3k |
| B. Riley Wealth Management, Inc. | New | +15.0k |
| Creative Planning | New | +11.8k |
| VANGUARD GROUP INC | New | +10.4k |
| ESSEX INVESTMENT MANAGEMENT CO LLC | New | +1.4k |
| WELLS FARGO & COMPANY/MN | Added | +4 |
Biggest sellers
| Millrace Asset Group, Inc. | Sold out | -81.1k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -21.4k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -15.6k |
| GOLDMAN SACHS GROUP INC | Sold out | -10.9k |
| NEUBERGER BERMAN GROUP LLC | Reduced | -500 |
| UBS Group AG | Reduced | -485 |
| Plante Moran Financial Advisors, LLC | Sold out | -200 |
| BlackRock Inc. | Reduced | -141 |
| Tower Research Capital LLC (TRC) | Reduced | -119 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| WASATCH ADVISORS LP 13G · institution -2.3 pts · filed 2026-10-09 | 11.0% |
| TANG CAPITAL MANAGEMENT LLC 13G · passive investor filed 2025-05-15 | 8.0% |
Fell to 5% or below in the last year: VANGUARD CAPITAL MANAGEMENT LLC (3.6%, 2026-07-31)
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2022.
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| BRC Group Holdings, Inc. 0.72% of their portfolio | 864.7k $3.2m | Unchanged |
| Opaleye Management Inc. 0.41% of their portfolio | 245.7k $919.0k | Added +178.7k |
| PERKINS CAPITAL MANAGEMENT INC 0.85% of their portfolio | 220.1k $823.0k | Added +28.3k |
| NEUBERGER BERMAN GROUP LLC 0.00% of their portfolio | 197.1k $737.0k | Reduced -500 |
| AMERICAN FINANCIAL GROUP INC 0.23% of their portfolio | 180.0k $673.0k | Unchanged |
| B. Riley Wealth Management, Inc. 0.00% of their portfolio | 15.0k $56.1k | New |
| Creative Planning 0.00% of their portfolio | 11.8k $44.0k | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 10.4k $39.0k | New |
| BlackRock Inc. 0.00% of their portfolio | 8.5k $32.0k | Reduced -141 |
| UBS Group AG 0.00% of their portfolio | 2.7k $10.0k | Reduced -485 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 2.0k $8.0k | Reduced -119 |
| ESSEX INVESTMENT MANAGEMENT CO LLC 0.00% of their portfolio | 1.4k $5.0k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 29 $0 | Added +4 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |